ELI LILLY AND COMPANY for ELI LILLY AND COMPANY

Immigration IMM

Administration Immigration Proclamation on non-immigrant visa categories

Contacted: State, Dept of (DOS); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Justice, Dept of (DOJ); Executive Office of the President (EOP); SENATE; U.S. Trade Representative (USTR)

Copyright/Patent/Trademark CPT

Prescription Drug Pricing Reduction Act (PDPRA) (S. 4199); Pharmaceutical intellectual property issues; Consolidated Appropriations Act, 2021 (H.R.133)

Contacted: Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Commerce, Dept of (DOC); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Justice, Dept of (DOJ); SENATE; Executive Office of the President (EOP); State, Dept of (DOS); U.S. Trade Representative (USTR)

Bills named: S. 4199 (116th), H.R. 133 (116th)

Health Issues HCR

Patient protection; drug supply chain and shortages; Drug pricing, value and access; Transparency; Intellectual Property; Health insurance accessibility; "Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act"; Consolidated Appropriations Act, 2021 (H.R.133)

Contacted: Justice, Dept of (DOJ); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Commerce, Dept of (DOC); Office of Management & Budget (OMB); Homeland Security, Dept of (DHS); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Executive Office of the President (EOP)

Bills named: H.R. 133 (116th)

Medicare/Medicaid MMM

Intellectual property; 340B Program; PPACA; Medicare & Medicaid prescription drug reimbursement, coverage, and value; Prescription Drug Pricing Reduction Act (PDPRA)(S.4199); Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 (DISARM Act)(S.1712); Consolidated Appropriations Act, 2021 (H.R.133)

Contacted: Office of Management & Budget (OMB); Homeland Security, Dept of (DHS); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Justice, Dept of (DOJ); State, Dept of (DOS); Commerce, Dept of (DOC)

Bills named: S. 4199 (116th), S. 1712 (116th), H.R. 133 (116th)

Pharmacy PHA

Hospital discounts; 340B program

Contacted: Justice, Dept of (DOJ); U.S. Trade Representative (USTR); Office of Management & Budget (OMB); State, Dept of (DOS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA)

Trade (domestic/foreign) TRD

Issues related to intellectual property protection and market access within current trade negotiations; Canada IP; USMCA implementation; Saudi Arabia; Mexico patent linkage; Special 301; Trade talks - US-Japan, US-China, US-EU, US-UK, US-Kenya, and US-Brazil

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); U.S. Trade Representative (USTR); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Homeland Security, Dept of (DHS); Food & Drug Administration (FDA); Office of Management & Budget (OMB); SENATE; Justice, Dept of (DOJ)

Taxation/Internal Revenue Code TAX

Implementation of the Tax Cuts and Jobs Act; Domestic manufacturing tax incentives; Puerto Rico tax issues; pension and retirement benefit issues; Consolidated Appropriations Act, 2021 (H.R.133)

Contacted: Homeland Security, Dept of (DHS); SENATE; Executive Office of the President (EOP); Commerce, Dept of (DOC); Food & Drug Administration (FDA); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Office of Management & Budget (OMB); Justice, Dept of (DOJ)

Bills named: H.R. 133 (116th)

Consumer Issues/Safety/Products CSP

Multi-lateral threats to IP and the biopharmaceutical industry; Drug importation; Prescription drug value and access

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); SENATE; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Justice, Dept of (DOJ); Food & Drug Administration (FDA); State, Dept of (DOS); Homeland Security, Dept of (DHS); Office of Management & Budget (OMB)